doi: 10.3389/fphar.2023.1146960 Received 18 January 2023 Accepted 14 August 2023 Published 28 August 2023 Volume 14 - 2023 Edited by Budheswar Dehury, Regional Medical Research Center (ICMR), India Reviewed by Yao-Hsiang Shih, Kaohsiung Medical University, Taiwan Chita Ranjan Sahoo, Siksha O Anusandhan University, India Sunita Panda, Regional Medical Research Center (ICMR), India Updates Copyright 2023 Guo, Lei, Zhao, Wu, Ren, Yang, Ouyang, Liu, Liu and Chen
You draw up a specific volume using an insulin syringe, giving you precise control over the dose
The most commonly reported events in active arms were mild and transient: injection site reactions in some subcutaneous subjects, occasional headache, and in some oral dosing arms, minor gastrointestinal tolerance issues
Notably, all have histone deacetylase inhibitory effects, but butyrate is the most potent inhibitor of class I and IIa histone deacetylase